Immunic IMUX
NASDAQ IMUX
$13.11 +0.35 (+2.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Immunic (IMUX) Price to FCF (2019 - 2026)

Analysis

Immunic (IMUX) Price to FCF (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Immunic 546.30 Mn 546.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -20.91
Mar 31, 2026 -19.33
Dec 31, 2025 -4.31
Sep 30, 2025 -8.46
Jun 30, 2025 -3.74
Mar 31, 2025 -4.50
Dec 31, 2024 -3.93
Sep 30, 2024 -7.13
Jun 30, 2024 -5.81
Mar 31, 2024 -4.95
Dec 31, 2023 -4.77
Sep 30, 2023 -3.78
Jun 30, 2023 -5.58
Mar 31, 2023 -3.37
Dec 31, 2022 -2.95
Sep 30, 2022 -7.07
Jun 30, 2022 -6.72
Mar 31, 2022 -15.97
Dec 31, 2021 -10.63
Sep 30, 2021 -13.19